Responses
Clinical/translational cancer immunotherapy
Original research
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study
Compose a Response to This Article
Other responses
No responses have been published for this article.
